Author:
Zhang Shunhao,Duan Sining,Xie Zhuojun,Bao Wanlin,Xu Bo,Yang Wenbin,Zhou Lingyun
Abstract
The transcription factor nuclear factor erythroid 2-related factor 2 (NRF2) and its negative regulator kelch-like ECH-associated protein 1 (KEAP1) regulate various genes involved in redox homeostasis, which protects cells from stress conditions such as reactive oxygen species and therefore exerts beneficial effects on suppression of carcinogenesis. In addition to their pivotal role in cellular physiology, accumulating innovative studies indicated that NRF2/KEAP1-governed pathways may conversely be oncogenic and cause therapy resistance, which was profoundly modulated by epigenetic mechanism. Therefore, targeting epigenetic regulation in NRF2/KEAP1 signaling is a potential strategy for cancer treatment. In this paper, the current knowledge on the role of NRF2/KEAP1 signaling in cancer oxidative stress is presented, with a focus on how epigenetic modifications might influence cancer initiation and progression. Furthermore, the prospect that epigenetic changes may be used as therapeutic targets for tumor treatment is also investigated.
Subject
Pharmacology (medical),Pharmacology
Reference222 articles.
1. Cognitive Deficits Triggered by Early Life Stress: The Role of Histone Deacetylase 1;Adler;Neurobiol. Dis.,2016
2. Nucleosidic DNA Demethylating Epigenetic Drugs - A Comprehensive Review from Discovery to Clinic;Agrawal;Pharmacol. Ther.,2018
3. Nrf2, a Cap'n'Collar Transcription Factor, Regulates Induction of the Heme Oxygenase-1 Gene;Alam;J. Biol. Chem.,1999
4. Glucocorticoid Receptor Signaling Represses the Antioxidant Response by Inhibiting Histone Acetylation Mediated by the Transcriptional Activator NRF2;Alam;J. Biol. Chem.,2017
5. Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters Using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice;Aleksunes;Drug Metab. Dispos.,2012
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献